Jamison Eaton & Wood’s AbbVie ABBV Stock Holding History

Jamison Eaton & Wood’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.4M	Buy	23,965 +1,525	+7%	+$92.1K	0.4%	64
2014 Q4	$1.47M	Sell	22,440 -335	-1%	-$21.1K	0.41%	64
2014 Q3	$1.31M	Sell	22,775 -250	-1%	-$13.9K	0.37%	66
2014 Q2	$1.3M	Sell	23,025 -250	-1%	-$13.1K	0.36%	65
2014 Q1	$1.2M	Sell	23,275 -1,600	-6%	-$80.9K	0.33%	67
2013 Q4	$1.31M	Hold	24,875	–	–	0.34%	67
2013 Q3	$1.11M	Hold	24,875	–	–	0.31%	69
2013 Q2	$1.03M	Buy	+24,875	New	+$1.09M	0.3%	70

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jamison Eaton & Wood's ABBV Position: Q1 2015 in Review

Jamison Eaton & Wood increased its AbbVie (ABBV) stake by 6.8% in Q1 2015, buying an estimated $92.1K and bringing the position to 23,965 shares worth $1.4M. The position accounts for 0.4% of the portfolio, ranked #64.

Jamison Eaton & Wood first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.47M in Q4 2014. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Jamison Eaton & Wood held 23,965 shares of AbbVie worth $1.4M as of Q1 2015.
Jamison Eaton & Wood bought 1,525 AbbVie shares in Q1 2015, an estimated $92.1K.
AbbVie made up 0.4% of Jamison Eaton & Wood's portfolio in Q1 2015, its #64 holding.
Jamison Eaton & Wood first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
Jamison Eaton & Wood's AbbVie position peaked at $1.47M in Q4 2014.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Jamison Eaton & Wood's 13F filing for Q1 2015, filed 30 Apr 2015.